Accretive Health, which provides technology-based solutions to improve hospitals' operating margins, announced terms for its IPO on Tuesday. The Chicago, IL-based company plans to raise $200 million by offering 13.3 million shares at a price range of $14-16. At the mid-point of the proposed range, Accretive Health will command a market value of $1.5 billion. Accretive Health, which was founded in 2003 and booked $510 million in sales last year, plans to list on the NYSE under the symbol AH. Goldman, Sachs & Co., Credit Suisse and J.P. Morgan are the lead underwriters on the deal, which is expected to price during the week of May 17th.
